Genetics of Diabetes
Diabetes encompasses type 1 (autoimmune beta-cell destruction) and type 2 (progressive insulin resistance and beta-cell dysfunction). Both have strong genetic components, with HLA genes dominating type 1 risk and common metabolic variants contributing to type 2 risk.
This page is for educational and informational purposes only. Not a diagnostic tool. Always consult a qualified healthcare provider.
What is Diabetes?
Type 1 diabetes (T1D) is an autoimmune condition where cytotoxic T cells destroy pancreatic beta cells, causing absolute insulin deficiency. HLA-DR3-DQ2 and HLA-DR4-DQ8 haplotypes account for ~50% of T1D genetic risk. PTPN22, INS, IL2RA, and CTLA4 variants contribute additional risk through immune dysregulation. Type 2 diabetes (T2D) involves a polygenic combination of insulin resistance and progressive beta-cell dysfunction. TCF7L2 rs7903146 is the strongest T2D risk variant. New-onset diabetes following COVID-19 has been documented, through multiple mechanisms including direct ACE2-expressing beta-cell infection, corticosteroid-induced hyperglycaemia, and immune-mediated beta-cell damage.
Biological pathways commonly discussed in relation to Diabetes
Research into Diabetes Mellitus — Type 1 and Type 2 Genetic Risk has highlighted several biological pathways that may be relevant. Genetic variants within these pathways may influence individual susceptibility, symptom severity, or the trajectory of the condition.
Beta Cell Function
Pancreatic beta cells sense glucose and secrete insulin. TCF7L2 (WNT signalling), KCNJ11/ABCC8 (potassium channel), and GCK (glucokinase) variants affect insulin secretion thresholds and beta-cell mass. Monogenic diabetes (MODY) results from single-gene mutations in beta-cell transcription factors.
Immune Mediated Diabetes
T1D involves CD8+ cytotoxic T cell destruction of beta cells presenting islet autoantigens (insulin, GAD65, IA-2). HLA class II genes determine antigen presentation efficiency. CTLA4, IL2RA, and PTPN22 variants affect T cell tolerance and regulatory T cell function.
Insulin Resistance Pathway
T2D insulin resistance involves impaired GLUT4 translocation, reduced IRS1/2 signalling, and compensatory hyperinsulinaemia. FTO, MC4R, and PPARG variants affect adiposity and insulin sensitivity. The T2D polygenic risk score incorporates hundreds of variants across metabolic pathways.
Pancreatic Inflammation
COVID-19 can cause pancreatic inflammation through direct beta-cell ACE2/TMPRSS2 infection, immune-mediated damage (cytokine storm), and microvascular thrombosis. Post-COVID new-onset T1D and T2D have been reported, with some studies suggesting accelerated autoimmune beta-cell destruction in genetically susceptible individuals.
Key genes studied in relation to Diabetes
The following genes have been studied in relation to Diabetes Mellitus — Type 1 and Type 2 Genetic Risk. These genes span the biological pathways most commonly discussed in this area of research.
Genetic variants commonly discussed
The following genetic variants (SNPs) are found in genes that have been studied in relation to Diabetes. Each variant represents a position in the genome where individuals may carry different alleles.
13 variants total across genes studied in relation to Diabetes.
How personal DNA data may provide educational insights
Consumer DNA files from 23andMe, AncestryDNA, and MyHeritage contain raw SNP data. When you upload your file to ChronicDNA, the analysis engine checks your genotype against a curated panel of 80+ genes selected for their relevance to Long COVID, ME/CFS, and connected biological pathways - some of which may relate to areas such as Diabetes.
This is not a diagnostic service. Genetic variants do not determine whether you have Diabetes, nor do they predict your clinical outcomes. The report is educational - it explains which variants you carry, what the research says about them, and how they fit into the biological pathways most relevant to chronic illness. All results should be discussed with a qualified healthcare provider.
Related conditions and pathways
Diabetes shares biological pathways and genetic associations with the following related conditions and areas of research.
Frequently asked questions
Can COVID-19 cause diabetes?
COVID-19 has been associated with new-onset diabetes in multiple large studies. Mechanisms include direct SARS-CoV-2 infection of ACE2-expressing beta cells, corticosteroid treatment causing stress hyperglycaemia, cytokine storm-induced beta-cell stress, and possible acceleration of autoimmune beta-cell destruction in genetically susceptible individuals. Both T1D-like and T2D-like presentations have been reported post-COVID.
What is the HLA contribution to type 1 diabetes?
HLA class II alleles account for approximately 50% of type 1 diabetes genetic risk. High-risk haplotypes HLA-DR3-DQ2 and HLA-DR4-DQ8 predispose to autoimmune beta-cell destruction by enabling efficient presentation of islet autoantigens to pathogenic CD4+ T cells. The protective HLA-DR15-DQ6 haplotype is associated with very low T1D risk.
What is TCF7L2 and why is it the strongest T2D gene?
TCF7L2 (transcription factor 7-like 2) is a WNT pathway transcription factor regulating GLP-1 receptor expression in beta cells. The rs7903146 T allele reduces GLP-1-stimulated insulin secretion and beta-cell proliferation. It is the strongest common single-SNP association with type 2 diabetes, with ~40% increased T2D risk per T allele in Europeans.
Which diabetes risk genes are studied?
T1D genes: HLA-DR/DQ, PTPN22, CTLA4, IL2RA, INS, SH2B3. T2D genes: TCF7L2, PPARG, KCNJ11, ABCC8, FTO, MC4R, SLC30A8, HNF1A. Both types: HLA alleles, immune regulatory genes, and beta-cell function genes.
Explore DNA insights
If you already have DNA data from 23andMe, AncestryDNA, or MyHeritage, upload your raw file to ChronicDNA and receive a personalised educational report covering genes studied in relation to Diabetes and connected biological pathways.
Get Your Personalised DNA ReportInformational and educational only · Not a diagnostic tool · GDPR compliant
7 genes · 13 variants analysed in relation to Diabetes